IP Library Granted Patent US 8,592,490
Granted Patent B2
US 8,592,490 · App. 12/521,386 · Granted Nov 26, 2013

Self-microemulsifying drug delivery systems

Inventors: Igor Legen (Grosuplje, SI); Janez Kerc (Ljubljana, SI); Polona Jurkovic (Ljubljana, SI)
Assignee: LEK Pharmaceuticals D.D.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,592,490
App. No.
12/521,386
Granted
Nov 26, 2013
Kind
B2
Abstract

Self-microemulsifying drug delivery systems and microemulsions used to enhance the solubility of pharmaceutical ingredients comprising a polyoxyethylene sorbitan fatty acid ester emulsifier; a fatty acid ester co-emulsifier and an oil.

Claims (16)

1. A self-microemulsifying drug delivery system consisting of:

(i) a polyoxyethylene sorbitan fatty acid ester emulsifier;

(ii) a co-emulsifier selected from glyceryl mono- or di-fatty acid esters of C 6 -C 18 fatty acids; and

(iii) an oil, selected from C 6 -C 12 fatty acid triglycerides;

wherein the polyoxyethylene sorbitan fatty acid ester emulsifier (i) and co-emulsifier (ii) are present in a ratio by weight of between 1:1 and 4:1 and

the emulsifier and co-emulsifier, (i)+(ii), and oil (iii) are present in a ratio by weight of between 4:1 and 10 000:1; and wherein said drug delivery system is stable on addition of any amount of water.

2. A self-microemulsifying drug delivery system according to claim 1 , wherein the emulsifier (i) is a polysorbate.

3. The self-microemulsifying drug delivery system of claim 2 , wherein the polysorbate is Polysorbate 80.

4. A self-microemulsifying drug delivery system according to claim 1 , wherein the ratios are selected from the group of ratios consisting of:

the polyoxyethylene sorbitan fatty acid ester emulsifier (i) and co-emulsifier (ii) are present in a ratio by weight of about 1:1, about 2:1, about 2.5:1, about 3:1, about 3.5:1 and about 4:1;

the ratio by weight of emulsifier and co-emulsifier, (i)+(ii), to oil (iii), is in the range selected from the group consisting of about 4:1 to 1000:1, about 4:1 to 100:1, and about 5:1 to 40:1; and

the ratio of coemulsifier (ii) to oil (iii) is selected from the group consisting of at least 1.5:1, at least 2:1, and at least 3:1.

5. A self-microemulsifying drug delivery system according to claim 1 , wherein the polyoxyethylene sorbitan fatty acid ester emulsifier (i) and co-emulsifier (ii) are present in a ratio by weight of between 2.5:1 and 3.5:1.

6. A self-microemulsifying drug delivery system according to claim 1 , wherein the co-emulsifier is selected from glyceryl mono- or di-fatty acid esters of C 6 -C 12 fatty acids.

7. The self-microemulsifying drug delivery system according to claim 6 , wherein the co-emulsifier is glyceryl caprylate.

8. A self-microemulsifying drug delivery system according to claim 1 , wherein the oil is a caprylic or a capric triglyceride oil.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2010
From: LEGEN, IGOR; KERC, JANEZ; JURKOVIC, POLONA
To: LEK PHARMACEUTICALS D.D.
Reel/Frame 024993/0020 →
Priority Claims (1)
EP 06127228 · Dec 27, 2006 · regional
Continuity (1)
Related Publication 20100331356A1 · Dec 30, 2010